The landscape of price target revisions has been dominated by a flurry of activity in the financials sector, balanced against a series of recalibrations across consumer staples and discretionary names. As of the data captured on June 27, 2026, analysts have been active in adjusting their outlooks, particularly following a cluster of moves from Truist Securities.
* Truist Securities issued a broad sweep of upgrades across six major financial institutions, signaling a collective shift in sentiment for the group. * Nike (NKE) experienced significant downward pressure on its price targets, with two separate firms lowering their expectations for the stock. * McCormick (MKC) saw conflicting revisions, as an upgrade from UBS was countered by two downward adjustments from other major analysts.
Notable adjustments
The financial sector provided the most consistent narrative yesterday. Truist Securities revised targets upward for a basket of banking giants: JPM moved from 332 to 344, BAC climbed from 61 to 64, and C saw an increase from 147 to 158. Additionally, USB, PNC, and WFC each received bumps, with WFC notably lifted to 94 from a prior 90.
Elsewhere, the divergence on McCormick (MKC) is striking. While UBS nudged the target up to 52 from 51, TD Cowen and Bernstein moved in the opposite direction, dropping the target to 60 and 68, respectively. This split sentiment underscores the difficulty in pricing consumer staples in the current environment. Meanwhile, Nike remains a focal point of revision volatility; Deutsche Bank slashed its target from 51 to 43, while Oppenheimer took a more aggressive stance, cutting its mark from 120 to 60.
| Ticker | Firm | Dir | Prior → Current |
|---|---|---|---|
| NKE | Oppenheimer | Down | 120 → 60 |
| FDX | Truist Securities | Down | 425 → 365 |
| AMAT | Wells Fargo | Up | 715 → 740 |
| ZTS | Stifel | Down | 95 → 85 |
Broader watchlist context
The scope of revisions extends into industrial and healthcare names as well. FedEx (FDX) saw a substantial reduction by Truist Securities, moving from 425 to 365. In healthcare, both Zoetis (ZTS) and Boston Scientific (BSX) faced downward target adjustments from Stifel, shifting to 85 and 65, respectively. These moves are a reminder that even established large caps are subject to periodic cooling in consensus expectations.
One name worth isolating is Applied Materials (AMAT), which bucked the trend of many industrial-adjacent revisions by securing an upgrade to 740 from Wells Fargo. While this move highlights continued interest in the IT hardware space, it is worth tracking the full list of recent moves to see how these localized shifts align with the broader sector performance. Investors should look closely at these, as the variance between individual analyst consensus and market reality remains fluid.